Versican undergoes specific alterations in the fine molecular structure and organization in human aneurysmal abdominal aortas

Biomedical Chromatography

Volumn 17, Issue 6, 2003, Pages 411-416

  Theocharis, Achilleas D ^a   Tsolakis, I ^b   Hjerpe, A ^a   Karamanos, N K ^c  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b UNIVERSITY OF PATRAS   (Greece)

^c UNIVERSITY OF PATRAS   (Greece)

Author keywords

Abdominal aorta; Chondroitin sulfate; Disaccharides; Versican

Indexed keywords

BLOOD VESSELS; CHAINS; ELECTROPHORESIS; GEL PERMEATION CHROMATOGRAPHY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HISTOLOGY; PROTEINS; SULFUR COMPOUNDS;

ABDOMINAL AORTA; AORTIC WALLS; BIOLOGICAL FUNCTIONS; CHONDROITINSULFATE; DISACCHARIDE; DISEASED TISSUES; GLYCOSAMINOGLYCANS; MATRIX; PROTEOGLYCANS; VERSICAN;

TISSUE;

CHONDROITIN SULFATE; CORE PROTEIN; DERMATAN SULFATE; DISACCHARIDE; GLYCOSAMINOGLYCAN; VERSICAN;

ABDOMINAL AORTA ANEURYSM; ADULT; AGED; ANION EXCHANGE CHROMATOGRAPHY; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN TISSUE; IMMUNOBLOTTING; MALE; POLYACRYLAMIDE GEL ELECTROPHORESIS; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN ISOLATION; PROTEIN STRUCTURE; SUBSTITUTION REACTION;

EID: 0141702040     PISSN: 02693879     EISSN: None     Source Type: Journal    
DOI: 10.1002/bmc.263     Document Type: Article

References (33)

1. 2+ mediated LDL oxidation. FEBS Letters 1997; 403: 154-158.
2. Albertini R, DeLuca G, Passi A, Morati R and Abuja PM. Chondroitin 4-sulfate protects high-density lipoproteins against copper-dependent oxidation. Archives of Biochemistry and Biophysics 1999; 365: 143-149.
3. Aspberg A, Binkert C and Ruoslahti E. The versican C-type lectin domain recognizes the adhesion protein tenascin-R. Proceedings of National Academy of Sciences USA 1995; 92: 10590-10594.
4. Aspberg A, Adam S, Kostka G, Timpl R and Heinegard D. Fibulin-1 is a ligand for the C-type lectin domains of aggrecan and versican. Journal of Biological Chemistry 1999; 274: 20444-20449.
5. Bitter T and Muir H. A modified uronic acid carbazole reaction. Analytical Biochemistry 1962; 4: 330-334.
6. Camejo G, Hurt-Camejo E, Wiklund O and Bondjers G. Association of apoB-lipoproteins with arterial proteoglycans pathological significance and molecular basis. Atherosclerosis 1998; 139: 205-222.
7. Carlson DM. Structures and immunochemical properties of oligosaccharides isolated from pig submaxillary mucins. Journal of Biological Chemistry 1968: 243: 616-626.
8. Cherchi GM, Coinu R, Demuro P, Formato M, Sanna G, Tidore M, Tira ME and DeLuca G. Structural and functional modifications of human aorta proteoglycans in atherosclerosis. Matrix 1990; 10: 362-372.
9. Evanko SP, Angello C and Wight TN. Formation of hyaluronan- and versican-rich pericellular matrix is required for proliferation and migration of vascular smooth muscle cells. Arteriosclerosis Thrombosis and Vascular Biology 1999; 19: 1004-1013.
10. Freestone T, Turner RJ, Coady A, Higman DJ, Greenhalgh RM and Powell JT. Inflammation and matrix metalloproteinases in the enlarging abdominal aortic aneurysm. Arteriosclerosis Thrombosis and Vascular Biology 1995; 15: 1145-1151.
11. Halpert I, Sires UI, Roby JD, Potter-Perigo S, Wight TN, Shapiro SD, Welgus HG, Wickline SA and Parks WC. Matrilysin is expressed by lipid-laden macrophages at sites of potential rupture in atherosclerosic lesions and localizes to areas of versican deposition, a proteoglycan substrate for the enzyme. Proceedings of National Academy of Science USA 1996: 93: 9748-9753.
12. Hurt-Camejo E, Camejo G, Rosengren B, Lopez F, Ahlstrom C, Fager G and Bondjers G. Effect of arterial proteoglycans and glycosaminoglycans on low-density lipoprotein oxidation and its uptake by human macrophages and arterial smooth muscle cells. Arteriosclerosis Thrombosis 1992; 12: 569-583.
13. Iozzo RV. Matrix proteoglycans from molecular design to cellular function. Annual Review of Biochemistry 1998; 67: 609-652.
14. Karamanos NK, Hjerpe A, Tsegenidis T, Engfeldt B and Antonopoulos CA. Determination of iduronic acid and glucuronic acid in glycosaminoglycans after stoichiometric reduction and depolymerization using high-performance liquid chromatography and ultraviolet detection. Analytical Biochemistry 1988; 172: 410-419.
15. Karamanos NK, Syrokou A, Vanky P, Nurminen M and Hjerpe A. Determination of 24 variously sulfated galactosaminoglycan- and hyaluronan-derived disaccharides by high-performance liquid chromatography. Analytical Biochemistry 1994; 221: 189-199.
16. Kjellen L and Lindahl U. Proteoglycans structures and interactions. Annual Review of Biochemistry 1991; 60: 443-475.
17. Lemire JM, Braun K, Maurel P, Kaplan E, Schwartz S and Wight TN. Versican/PG-M isoforms in vascular smooth muscle cells. Arteriosclerosis Thrombosis and Vascular Biology 1999; 19: 1630-1639.
18. Lemire JM, Merrilees MJ, Braun KR and Wight TN. Overexpression of the V3 variant of versican alters arterial smooth muscle cell adhesion, migration, and proliferation in vitro. Journal of Cellular Physiology 2002: 190: 38-45.
19. Makatsori E, Karamanos NK, Anastassiou ED, Hjerpe A and Tsegenidis T. A method to quantitate total sialic acid, glucosamine, and galactosamine in blood serum and glycoconjugates by HPLC. Journal of Liquid Chromatography and Related Technologies 1998; 21: 3031-3045.
20. Passi A, Negrini D, Albertini G, Miserocchi G and DeLuca G. The sensitivity of versican from rabbit lung to gelatinase A (MMP-2) and B (MMP-9) and its involvement in the development of hydraulic lung edema. FEBS Letters 1999; 456: 93-96.
21. Sandy JD, Westling J, Kenagy RD, Iruela-Arispe ML, Verscheren C, Rodriquez-Mazaneque JC, Zimmermann DR, Lemire JM, Fischer JW, Wight TN and Clowes AW. Versican V1 proteolysis in human aorta in vivo occurs at the Glu441-Ala442 bond, a site that is cleaved by recombinand ADAMTS-1 and ADAMTS-4. Journal of Biological Chemistry 2001; 276: 13372-13378.
22. 1 on the synthesis of a large versican-like chondroitin sulfate proteoglycan by arterial smooth muscle cells. Journal of Biological Chemistry 1991: 266: 17640-17647.
23. Theocharis AD. Human colon adenocarcinoma is associated with specific post-translational modifications of versican and decorin. Biochimica et Biophysica Acta 2002; 1588: 165-172.
24. Theocharis AD and Karamanos NK. Decreased biglycan expression and differential decorin localization in human abdominal aortic aneurysms. Atherosclerosis 2002; 165: 221-230.
25. Theocharis AD and Theocharis DA. High-performance capillary electrophoretic analysis of hyaluronan and galactosaminoglycan-disaccharides in gastrointestinal carcinomas. Differential disaccharide composition as a possible tool-indicator for malignancies. Biomedical Chromatography 2002; 16: 157-161.
26. Theocharis AD, Tsolakis I, Tsegenidis T and Karamanos NK. Human abdominal aortic aneurysm is closely associated with compositional and specific structural modifications at the glycosaminoglycan level. Atherosclerosis 1999; 145: 359-368.
27. 0. Atherosclerosis 2001; 154: 367-376.
28. Theocharis AD, Karamanos NK, Papageorgakopoulou N, Tsiganos CP and Theocharis DA. Isolation and characterization of matrix proteoglycans from human nasal cartilage. Compositional and structural comparison between normal and scoliotic tissues. Biochimica et Biophysica Acta 2002a: 1569: 117-126.
29. Theocharis AD, Theocharis DA, DeLuca G, Hjerpe A and Karamanos NK. Compositional and structural alterations of chondroitin and dermatan sulfates during the progression of atherosclerosis and aneurysmal dilatation of human abdominal aorta. Biochimie 2002b; 84: 667-674.
30. Theocharis AD, Vynios DH, Papageorgakopoulou N, Skandalis SS and Theocharis DA. Altered content composition and structure of glycosaminoglycans and proteoglycans in gastric carcinoma. International Journal of Biochemistry and Cell Biology 2003; 35: 376-390.
31. Tsara M, Theocharis AD and Theocharis DA. Compositional and structural alteration of proteoglycans in human rectum carcinoma with special reference to versican and decorin. Anticancer Research 2002; 22: 2893-2898.
32. Westergren-Thorsson G, Schmidtchen A, Sarnstrand B, Fransson LA and Malmstrom A. Transforming growth factor-beta induces selective increase of proteoglycan production and changes in the copolymeric structure of dermatan sulphate in human skin fibriblasts. European Journal of Biochemistry 1992; 205: 277-286.
33. Wight TN. Arterial wall. In Extracellular Matrix, Comper WD (ed.). Harwood Academic: Amsterdam, 1996; 175-202.